Chevy Chase, Maryland, United States Funds with similar focus
| Fund Name | Location |
| ADM Capital | China, Hong Kong, Hong Kong Island |
| Allegra Capital | Australia, Perth, Western Australia |
| BIC Gipuzkoa Berrilan | Autonomous Community of the Basque Country, Éibar, Spain |
| Comma Capital | - |
| Deveaux Group | Aquitaine, France, New Aquitaine |
| EH Capital Partners | China, Shanghai |
| Gemssi Oy | - |
| IPPO | Japan, Kanagawa Prefecture, Kawasaki |
| KnowledgeHub | Mazowieckie, Poland, Warszawa |
| Koudai Information Technology | China, Hangzhou, Zhejiang |
| Magna Capital Partners | Chicago, Illinois, United States |
| Nex.D | Gdansk, Poland, Pomorskie |
| One Team Partners | District of Columbia, United States, Washington |
| Originate | California, San Francisco, United States |
| Outrun Ventures | England, London, United Kingdom |
| Pario Ventures | - |
| SEIF | Switzerland, Zurich, Zurich |
| Shaw Media | Canada, Ontario, Toronto |
| Technology Gateway Partnership | California, Irvine, United States |
| Tomato Bank | Japan, Okayama, Okayama Prefecture |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Argolyn Bioscience | $1M | 01 Sep 2003 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Argolyn Bioscience | $1M | 01 Sep 2003 | Durham, North Carolina, United States |
